hrp0098p2-125 | Fat, Metabolism and Obesity | ESPE2024

The Metabolic Effect of Liraglutide as Add on Treatment to Lifestyle Modification on Obese Adolescents in a Tertiary Centre, Riyadh.

Aljarallah Gadah , Albaraki Joud , Alharbi Reem , Alsomali Nouf , Alkhalaf Abeer , Yenugadhati Nagarajkumar , Alfaraidi Haifa , Babiker Amir

Background: Childhood obesity, defined as having a BMI ³95th percentile for age and gender, can have serious consequences, hence; new treatments are needed. Liraglutide, a glucagon-like peptide-1 hormone, is the first FDA-approved therapy for adolescents’ obesity in over a decade. This study aim ed to evaluate the efficacy of liraglutide for weight loss and other metabolic parameters in children with obesity in Saudi Arabia.<s...

hrp0098p2-226 | Pituitary, Neuroendocrinology and Puberty | ESPE2024

A High Rate of abnormal Cranial MRI in Saudi Girls with Central Precocious Puberty: Single Center Experience

Aljuraibah Fahad , Alharbi Mashael , Alharbi Reem , Alhammad Abullah , Aldharman Sarah , Alghamdi Hala , Albaraki Joud

Background: Precocious puberty refers to the early development of secondary sexual characteristics in girls before the age of eight. It is classified into two categories based on the cause: central (GnRH dependent) and peripheral (GnRH independent) precocious puberty. Brain MRI is the most commonly used method to assess underlying brain pathology, particularly in girls under the age of six.Objective: The aimof this study...